Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis

Aliment Pharmacol Ther. 2016 Aug;44(3):310-1. doi: 10.1111/apt.13692.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Adalimumab*
  • Antibodies, Monoclonal
  • Colitis, Ulcerative*
  • Humans
  • Prospective Studies

Substances

  • Antibodies, Monoclonal
  • golimumab
  • Adalimumab